Partnering

Akaal Pharma is developing novel, safer, and highly effective drugs to address diseases with significant unmet medical needs. Through its unique drug development platform, Akaal Pharma has identified drug candidates with distinctive oral and topical properties that meet rigorous criteria for further development. The company’s lead candidates are highly selective modulators of S1P1, offering a unique efficacy and safety profile that opens new therapeutic opportunities for inflammatory and autoimmune indications.

For partnering, collaboration or investment opportunities, please contact us at info@akaalpharma.com